Acute renal failure under dasatinib therapy

Renal Failure
Sultan OzkurtMehmet Soydan

Abstract

Dasatinib is a second-generation tyrosine kinase inhibitor that is approved for the treatment of imatinib-resistant or imatinib-intolerant chronic myeloid leukemia. It has a 325 times stronger in vitro activity against to native BCR-ABL when comparing with imatinib. Little is known about the effects of dasatinib on renal function. A literature review revealed only one case with imatinib-resistant chronic myeloid leukemia that developed renal failure after being placed on dasatinib therapy. Here we report a patient with imatinib-resistant chronic myeloid leukemia who developed gastroenteritis and acute renal failure after a short time from the initiation of dasatinib therapy. After dasatinib interruption, these side effects resolved completely in days. In summary, dasatinib is a potent drug in the treatment of chronic myeloid leukemia, but close clinical monitoring and the timely interruption of the therapy in patients who developed acute renal failure are warranted.

References

Mar 28, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Chagriya Kitiyakara, Vichai Atichartakarn
Feb 16, 2005·Cancer Cell·Ellen WeisbergJames D Griffin
Nov 17, 2005·The Annals of Pharmacotherapy·John R ForingerJayarama S Guntupalli
Jan 25, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Helene FrançoisPierre Ronco
Apr 19, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Lisa J ChristopherRamaswamy A Iyer
Feb 25, 2009·Journal of Hematology & Oncology·Siu-Fun Wong

❮ Previous
Next ❯

Citations

Feb 12, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M S MarcolinoA L Ribeiro
Dec 7, 2013·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Rebecca L RuebnerBernard S Kaplan
Apr 2, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Eric WallaceHuma Fatima
May 3, 2011·Advances in Chronic Kidney Disease·Nikolas Harbord
Apr 30, 2015·Targeted Oncology·Anum AbbasKetki Tendulkar
Jul 15, 2015·Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society·Katia Sotelo MongeAnna Matheu
Mar 23, 2011·Expert Review of Anticancer Therapy·Pasquale NiscolaPaolo de Fabritiis
Jun 17, 2020·Current Diabetes Reports·Christopher D Wiley
Nov 6, 2013·Journal of Clinical Pharmacy and Therapeutics·G KaiafaA I Hatzitolios
Apr 10, 2017·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Terry King-Wing MaFrederick Wai Keung Tam
May 2, 2020·World Journal of Clinical Oncology·Maria Luísa Cordeiro SantosFabrício Freire de Melo
Feb 23, 2021·Environmental Toxicology and Pharmacology·Nabila M E HassanEman Said
Jul 9, 2021·Kidney Research and Clinical Practice·Min Hee Hong

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.